Kelley Wright
Investment Q Trends
Chuck Carlson
The DRIP Investor
Paul Goodwin
Cabot China & Emerging Markets Report
John Reese
Validea

Melco Crown: China gaming gamble


Bookmark and Share
by Paul Goodwin, editor Cabot China & Emerging Markets Report

Paul GoodwinAn old friend we’re recommending again is Melco Crown Entertainment (MPEL), a Hong Kong company that owns one of the scarce gambling concessions in Macau, the only place in China where gambling is legal.

Casinos make more of their money by attracting high spenders, and China has plenty of those. Macau is also within excursion-boat range of Hong Kong and attracts lots of day trippers, who provide a significant amount of revenue.

In Macau, the competition among Las Vegas Sands properties, Wynn casinos and MGM Grand developments is fierce, but Melco Crown has played the mega-casino development game shot-for- shot with the big guys and is thriving.

The big driver of revenue for Melco is its City of Dreams resort casino complex, a massive conglomeration of casinos, hotels, theaters, 20 restaurants and bars, 175,000 square feet of high-end shopping venues
and water shows powered by 550 gambling tables, and 1,500 gaming machines.


This partially completed development contributes almost two-thirds of Melco’s revenue, with the Altira Macau kicking in just under a third. Smaller venues like the company’s Mocha Clubs, aimed at casual day trippers, make up the rest.

Gambling revenue from Macau topped that of Las Vegas in 2007, and big gaming companies have been pouring money into this tiny area.

Melco is locked in a building battle with its competitors, but City of Dreams is scheduled for completion in 2015, much earlier than rival developments. And as the Chinese economy revives, money flow will continue to increase.

Melco reported earnings on February 6, and revenue was up 9%. Earnings were flat, but investors were impressed by the 10.1% after-tax profit margin and estimates of 22% earnings growth in 2013.

We owned MPEL from late April 2011 until October of that year, cashing out with a profit as the stock was beginning a year-long correction caused by a slowing Chinese economy. MPEL bottomed at 10 last July and has been in an uptrend since.

The stock took a minor hit just as earnings came out because of a rumor that the Chinese government was going to crack down on gambling junkets from the mainland.

It took only a couple of days for this pullback, which dropped the stock below its 25-day moving average for the first time since December, to be recovered fully. MPEL is back near $21, which was resistance earlier this month. It’s buyable on any dip of half a point, or on a breakout over $21.

Learn more about this financial newsletter at Paul Goodwin's Cabot China & Emerging Markets Report.

Related articles


Advertisement
Banner
News Flash

US Natural Gas ETF: On a roll
by Doug Fabian, editor Successful Investing

One area I think is ready for a new buy is natural gas. After experiencing a sharp decline from November through early January, natural gas prices have been on a roll.


Read more...

 

Split buys? HOMB and Noble Energy
by Neil Macneale, editor 2-for-1 Stock Split Newsletter

Each month, we add one stock to our model portfolio based upon those companies that have announced 2-for-1 stock splits; after a meager number of splits over the past year, we have a nice collection of six splits elect from this month.


Read more...


   

WisdomTree targets global bonds
by Mark Salzinger, editor The Investor's ETF Report

While most investors diversify the equity portions of their portfolio with allocations to foreign stocks, few diversify their bond holdings internationally. WisdomTree recently introduced the first ETF to invest in a truly global portfolio of corporate bonds.


Read more...

 

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...

 

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary